Patents by Inventor Angela Koehler

Angela Koehler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233576
    Abstract: SLC46A3 has been identified as a lipid-based nanoparticle-specific biomarker predictive of nanoparticle-cancer cell affinity. SLC46A3 has a strong inverse association with lipid-based nanoparticle uptake across multiple nanoparticle formulations. Tissues with decreased expression levels of SLC46A3 have a greater uptake of lipid-based nanoparticles. The inverse relationship of SLC46A3 expression in tumor tissue and affinity for lipid-based nanoparticles has therapeutic and diagnostic implications, including cancer therapy and diagnosis, and identification of patients most likely to benefit from a lipid-based nanotherapeutic for improved stratification in clinical trials.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 28, 2022
    Inventors: Natalie BOEHNKE, Joelle Payne STRAEHLA, Angela KOEHLER, Paula HAMMOND
  • Publication number: 20200187532
    Abstract: A method for producing caviar or a caviar-like product from live, mature eggs of fish or crustaceans, wherein the eggs are in a fertile but unfertilized state and have a natural potassium content in the egg plasma, includes: treating the eggs in a saline solution which does not damage the eggs and subsequently treating the live, mature eggs in a solution of water and potassium in a concentration which does not damage the eggs and does not change the eggs' potassium content. The water is deionized prior to the addition of a potassium donor for forming a cationic component in the solution, the solution has a temperature that does not damage the eggs, and the eggs are treated in the solution for a duration of a potassium exposure time until an egg membrane of the eggs obtains a desired elastic stabilization.
    Type: Application
    Filed: December 16, 2019
    Publication date: June 18, 2020
    Inventor: Angela Koehler-Guenther
  • Patent number: 8039032
    Abstract: A method for processing ovulated eggs of an aquatic animal into delicacy foods. Ovulated eggs are harvested without harmful intervention of the aquatic animal. The harvested ovulated eggs are exogenously treated in an aqueous solution by adding at least one signal transduction molecule. Accordingly the membrane of the egg is physiologically stabilized by ovoperoxidase activation. The signal transduction molecule is naturally occurring in the egg cell. The eggs are then preserved.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: October 18, 2011
    Assignee: Stiftung Alfred-Wegener-Institut Fuer Polar-und Meeresforschung
    Inventor: Angela Koehler-Guenther
  • Publication number: 20090246335
    Abstract: A method for processing ovulated eggs of an aquatic animal into delicacy foods. Ovulated eggs are harvested without harmful intervention of the aquatic animal. The harvested ovulated eggs are exogenously treated in an aqueous solution by adding at least one signal transduction molecule. Accordingly the membrane of the egg is physiologically stabilized by ovoperoxidase activation. The signal transduction molecule is naturally occurring in the egg cell. The eggs are then preserved.
    Type: Application
    Filed: October 18, 2006
    Publication date: October 1, 2009
    Applicant: Stiftung Alfred-Wegener-Institut fuer Polar-und Meeresforschung
    Inventor: Angela Koehler-Guenther
  • Publication number: 20050123902
    Abstract: The present invention provides systems for identifying anti-viral agents. In particular, the invention encompasses reagents and strategies for identifying agents that inhibit or disrupt key protein-protein interactions that are important in the life cycle of papillomaviruses. The invention allows identification, production, and/or use of agents that reduce or inhibit the replication of HPV by inhibiting (e.g., precluding, reversing, or disrupting) the formation of the E1-E2 protein-protein complex. The invention also provides specific inhibitory agents, pharmaceutical compositions, and methods of using these inhibitors and pharmaceutical compositions for inhibiting viral replication in vitro. Methods are also described for the treatment and prevention of HPV infections and HPV-related diseases in patients.
    Type: Application
    Filed: May 21, 2004
    Publication date: June 9, 2005
    Inventors: Patricio Meneses, Angela Koehler, Jason Wong, Peter Howley, Stuart Schreiber
  • Publication number: 20050095639
    Abstract: The present invention provides compositions and methods to facilitate the identification of compounds that are capable of interacting with a biological macromolecule of interest. In one aspect, a composition is provided that comprises an array of one or more types of chemical compounds attached to a solid support, wherein the density of the array of compounds is at least 1000 spots per cm2. In particularly preferred embodiments, these compounds are attached to the solid support through a covalent interaction.
    Type: Application
    Filed: November 29, 2004
    Publication date: May 5, 2005
    Inventors: Stuart L. Schreiber, Gavin MacBeath, Angela Koehler, Paul Hergenrother, Kristopher Depew